New FMI Report Explores Impact of COVID 19 Outbreak on Muscle Stimulation Device
Posted by aliena on February 2nd, 2021
The global muscle stimulation devices market is slated to grow passively, at a 3.9% CAGR during 2018-2028. Rising incidences of spinal cord and head injuries is likely to boost growth of the global market during the assessment period. Furthermore, higher number of fitness enthusiasts and athletes use electrical muscle stimulators to improve their training regimens and fitness. These devices are also utilized in home care settings and gyms to amplify exercise programs.
“Combination therapy using MS, US, and IFT devices are trending the Asia Pacific market, particularly for lower back pain and joint pain. Thus, several companies in APAC are projected to target physiotherapy clinics and hospitals, for expanding portable combination device sales.” states the FMI analyst.
Request a report sample to gain comprehensive market insights at https://www.futuremarketinsights.com/reports/sample/rep-gb-1140
COVID-19 Impact on Muscle Stimulation Devices Market
The need for lifesaving medical devices is unlike anything the healthcare sector with the onset of COVID-19 pandemic. The muscle stimulation devices market is foreseeing a notable surge in demand as notably large number of patients with COVID-19 necessitates long ICU admission and longer stays are likely to develop ICU-acquired weakness.
Key players in the muscle stimulation devices market are fortifying product portfolio by presenting new products with enhanced features, and via strategic m&a. Furthermore, a rising number of local players will result in forming a fragmented market, as the market is already led by smaller-sized companies fulfilling the domestic consumer demands.
Some of the players identified in the global market are Omron Corporation, R.S. Medical Inc., Neurometrix Inc., Zynex Inc., and DJO Global Inc.
Like it? Share it!
About the Authoraliena
Joined: August 4th, 2020
Articles Posted: 449
More by this author